Promotion of prescription drugs and its impact on physicians' choice behavior

Journal of Marketing

Volumn 65, Issue 3, 2001, Pages 79-90

  Gönül, Füsun F ^a   Carter, Franklin ^a   Petrova, Elina ^a   Srinivasan, Kannan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035633187     PISSN: 00222429     EISSN: None     Source Type: Journal    
DOI: 10.1509/jmkg.65.3.79.18329     Document Type: Article

References (23)

1. Berndt, Ernst R., Linda T. Bui, David H. Reiley, and Glen L. Urban (1994), "The Roles of Marketing, Product Quality, and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry," Working Paper No. 19-94, Program on the Pharmaceutical Industry, Massachusetts Institute of Technology.
2. Bonoma, Thomas V. (1982), "Major Sales: Who Really Does the Buying?" Harvard Business Review, 60 (May/June), 111-19.
3. Chamberlain, Gary (1980), "Analysis of Covariance with Qualitative Data," Review of Economic Studies, 47, 225-38.
4. Gönül, Füsun F., Franklin Carter, and Jerry Wind (2000), "What Kinds of Patients and Physicians Value Direct-to-Consumer Advertising of Prescription Drugs?" Health Care Management Science, 3, 215-26.
5. Hellerstein, Judith K. (1997), "The Demand for Post-patent Prescription Pharmaceuticals," RAND Journal of Economics.
6. Hurwitz, Mark A. and Richard E. Caves (1988), "Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals," Journal of Law and Economics, 31 (October), 299-320.
7. Kamakura, Wagner A. and Gary J. Russell (1989), "A Probabilistic Choice Model for Market Segmentation and Elasticity Structure," Journal of Marketing Research, 26 (November), 379-90.
8. Kotler, Philip (2000), Marketing Management: Millenium Edition. Englewood Cliffs, NJ: Prentice Hall.
9. Krapfel, Robert E., Jr. (1985), "An Advocacy Behavior of Organizational Buyers' Vendor Choice," Journal of Marketing, 49 (4), 51-59.
10. Leffler, Keith B. (1981), "Persuasion or Information? The Economics of Prescription Drug Advertising," Journal of Law and Economics, 24 (April), 45-74.
11. Marks, Lawrence J. and Michael A. Kamins (1988), "The Use of Product Sampling and Advertising: Effects of Sequence of Exposure and Degree of Advertising Claim Exaggeration on Consumers' Belief Strength, Belief Confidence, and Attitudes," Journal of Marketing Research, 25 (August), 266-81.
12. McFadden, Daniel (1974), "Conditional Logit Analysis of Qualitative Choice Behavior," in Frontiers of Economics, P. Zarembka, ed. New York: Academic Press, 105-42.
13. Milgrom, Paul and J. Roberts (1982), "Limit Pricing and Entry Under Incomplete Information: An Equilibrium Analysis," Econometrica, 50 (March), 443-59.
14. _ and _ (1986), "Price and Advertising Signals of Product Quality," Journal of Political Economy, 94 (4), 796-821.
15. Miller, Robert H. and Harold S. Luft (1994), "Managed Care Plan Performance Since 1980: A Literature Analysis," Journal of the American Medical Association, 271 (19), 1512-19.
16. Mitra, Anusree and John G. Lynch Jr. (1995), "Toward A Reconciliation of Market Power and Information Theories of Advertising Effects on Price Elasticity," Journal of Consumer Research, 21 (March), 644-59.
17. Nelson, Paul (1970), "Information and Consumer Behavior," Journal of Political Economy, 20 (March/April), 311-29.
18. _ (1974), "Advertising as Information," Journal of Political Economy, 24 (July/August), 729-45.
19. Nerlove, Mark and Kenneth J. Arrow (1962), "Optimal Advertising Policy Under Dynamic Conditions," Economica, (May), 129-42.
20. Newhouse, Joseph P. (1993), Free for All? Lessons from the RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press.
21. PhRMA (1994), "Pharmaceutical Marketing Practices: Questions and Answers," paper presented at the PhRMA Marketing Practices Committee, Washington, DC (September).
22. Van Zandt, William (1993), "How Much Sampling Is Enough?" Pharmaceutical Executive, (September), 92-96.
23. Ziegler, Michael G., Pauline Lew, and Brian C. Singer (1995), "The Accuracy of Drug Information from Pharmaceutical Sales Representatives," Journal of the American Medical Association, 273 (16), 1296-98.